Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Core Viewpoint - Aethlon Medical, Inc. is set to release its financial results for the fiscal second quarter ending September 30, 2024, on November 13, 2024, at 4:15 p.m. ET [1] Group 1: Financial Results Announcement - The financial results will be discussed in a conference call on November 13, 2024, at 4:30 p.m. ET, which will include a question and answer session [2] - Interested parties can register for the conference call online, and registered participants will receive a dial-in number [2] Group 2: Conference Call Details - For those without internet access, a toll-free number is available for participation: 1-844-836-8741 for domestic calls and 1-412-317-5442 for international calls [3] - A replay of the conference call will be available approximately one hour after the call ends, accessible through Aethlon Medical's website or via specific phone numbers [4] Group 3: Company Overview - Aethlon Medical focuses on developing the Hemopurifier, an immunotherapeutic device aimed at treating cancer and life-threatening viral infections, as well as applications in organ transplantation [5] - The Hemopurifier has shown promise in human studies for removing life-threatening viruses and harmful exosomes, which may contribute to immune suppression and cancer metastasis [5] - The device has received FDA Breakthrough Device designation for treating advanced or metastatic cancer and life-threatening viruses not addressed by approved therapies [5]